Zichem Pharma SRL
Zichem Pharma reported total assets of 622,406 € at the end of the 2025 financial year (annual accounts filed with the NBB on 12 May 2026).
The score of Zichem Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +28 % Total assets +28 %
Accounts of the company itself (not consolidated).
The full file covers 12 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Zichem Pharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 40,263 € | ||||
| Equity | 538,245 € | ||||
| Cash | 4,119 € | ||||
| EBITDA | 50,167 € | ||||
| Total assets | 622,406 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 12 May 2026
- Year ended 31 Dec 2024filed on 16 Jun 2025
- Year ended 31 Dec 2023filed on 12 Jun 2024
- Year ended 31 Dec 2022filed on 09 Jun 2023
- Year ended 31 Dec 2021filed on 07 Jun 2022
Zichem Pharma's financial analysis
- Solvency86.5%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Zichem Pharma
Zichem Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0431.802.725
- VAT number
- BE0431802725
- Peppol
- Registered · 0208:0431802725 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 21 Aug 1987
- Registered office
- 3271 Scherpenheuvel-Zichem
- Latest accounts
- 2025 · filed on 12 May 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Zichem Pharma (SRL) has been based in Scherpenheuvel-Zichem since 1987, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 40,263 € and equity of 538,245 €; its revenue is not published. Its solvency stands at 86.5%, above the median of its sector (44.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Zichem Pharma
Companies in the same business, of comparable size and area, outside its group.
- Apotheek Queens Retail sale of pharmaceutical products Turnhout · balance sheet 621,995 €
- Pharmacie Pirenne Retail sale of pharmaceutical products Soumagne · balance sheet 622,922 €
- MVA Pharma Retail sale of pharmaceutical products Charleroi · balance sheet 621,644 €
- Bioclin Retail sale of pharmaceutical products Ostend · balance sheet 623,434 €
- Heldo Retail sale of pharmaceutical products Erpe-Mere · balance sheet 621,357 €
- Hubert Pellegrin Retail sale of pharmaceutical products Uccle · balance sheet 623,769 €
- Pharmadil Retail sale of pharmaceutical products Dilbeek · balance sheet 620,651 €
- PH de Linde Retail sale of pharmaceutical products Anderlecht · balance sheet 619,651 €
Frequently asked questions about Zichem Pharma
What is the revenue of Zichem Pharma?
Zichem Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Zichem Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0431802725 for Zichem Pharma, if the company is VAT-registered. Its company number (CBE) is 0431.802.725.
Where is the registered office of Zichem Pharma?
According to the CBE register, the registered office of Zichem Pharma is in 3271 Scherpenheuvel-Zichem.
What is the equity of Zichem Pharma?
At the close of the 2025 financial year, the equity of Zichem Pharma amounts to 538,245 €, a solvency of 86.5% of total assets.
Who manages Zichem Pharma?
The register lists 8 active mandates at Zichem Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Zichem Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →